Sign in Subscribe
COVID-19

Regenerative Medicine Market to Reach USD 49.94 Billion by 2027, Growing at a CAGR of 20.03%

Strategic Insights

— 2 min read

The global regenerative medicine market size was estimated at USD 16.69 billion in 2021 and is expected to reach USD 20.01 billion in 2022. This growth is driven by increasing adoption of stem cell technologies, gene therapies, and tissue engineering, as well as technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials. The market is expected to grow at a compound annual growth rate (CAGR) of 20.03% to reach USD 49.94 billion by 2027.

Key Takeaways:

  • The regenerative medicine market is expected to be driven by increasing adoption of stem cell technologies, gene therapies, and tissue engineering, with a projected growth rate of 20.03% CAGR from 2022 to 2027.
  • The market size was estimated at USD 16.69 billion in 2021 and is expected to reach USD 20.01 billion in 2022, indicating a growth of 19.74% in one year.
  • Major companies in the regenerative medicine market include Allergan, Amgen, Gilead Sciences, Integra LifeSciences, Medtronic, and Mimedx Group, among others.
  • The cumulative impact of COVID-19 on the market is significant, with projected effects on global trade dynamics, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States.
  • The competitive landscape analysis reveals the optimal or favorable fit for vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during the forecast period.
  • The market share analysis provides insights into the revenue generation and customer base comparison among vendors, offering an understanding of the size and competitiveness of vendors in the regenerative medicine market.
  • The report answers questions about market size and forecast, inhibiting factors, impact of COVID-19, and competitive strategic window for opportunities, among others.

Statistics:

  • Global regenerative medicine market size was estimated at USD 16.69 billion in 2021.
  • The market is expected to reach USD 20.01 billion in 2022, indicating a growth of 19.74% in one year.
  • Projected market size by 2027: USD 49.94 billion.
  • Expected compound annual growth rate (CAGR) from 2022 to 2027: 20.03%.
  • Market size projected by type in 2027:

+ Biologics: USD 12.81 billion.

+ Synthetic scaffolds: USD 5.22 billion.

+ Synthetic polymers: USD 3.61 billion.

+ Bioactive factors: USD 2.41 billion.

+ Others: USD 25.89 billion.

  • Market size projected by application in 2027:

+ Musculoskeletal disorders: USD 11.31 billion.

+ Cardiovascular disorders: USD 8.12 billion.

+ Neurological disorders: USD 6.46 billion.

+ Cancer: USD 4.57 billion.

+ Wound healing: USD 3.39 billion.

+ Others: USD 16.91 billion.

Sources:

  • "Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report.
  • ResearchAndMarkets.com.
  • BusinessWire.com article titled "Dublin -- The Regenerative Medicine Market Research Report by Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19".

Read more